EirGenix Future Growth
Future criteria checks 5/6
EirGenix is forecast to grow earnings and revenue by 120% and 42.3% per annum respectively. EPS is expected to grow by 119.9% per annum. Return on equity is forecast to be 3.9% in 3 years.
Key information
120.0%
Earnings growth rate
119.9%
EPS growth rate
| Life Sciences earnings growth | 25.6% |
| Revenue growth rate | 42.3% |
| Future return on equity | 3.9% |
| Analyst coverage | Low |
| Last updated | 23 Apr 2024 |
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 2,726 | 413 | 12 | 625 | 1 |
| 12/31/2024 | 2,286 | 332 | -293 | 185 | 1 |
| 12/31/2023 | 1,023 | -915 | -1,577 | -849 | N/A |
| 9/30/2023 | 987 | -618 | -1,460 | -873 | N/A |
| 6/30/2023 | 1,138 | -533 | -1,285 | -761 | N/A |
| 3/31/2023 | 1,336 | -333 | -926 | -421 | N/A |
| 12/31/2022 | 1,481 | -116 | -936 | -148 | N/A |
| 9/30/2022 | 1,483 | -4 | -261 | 44 | N/A |
| 6/30/2022 | 1,778 | 355 | 216 | 488 | N/A |
| 3/31/2022 | 1,814 | 201 | 62 | 246 | N/A |
| 12/31/2021 | 1,697 | -43 | -200 | -30 | N/A |
| 9/30/2021 | 1,511 | -341 | -62 | 55 | N/A |
| 6/30/2021 | 1,247 | -743 | -554 | -499 | N/A |
| 3/31/2021 | 1,085 | -923 | -639 | -588 | N/A |
| 12/31/2020 | 1,072 | -1,042 | -462 | -419 | N/A |
| 9/30/2020 | 991 | -1,029 | -714 | -634 | N/A |
| 6/30/2020 | 688 | -1,260 | -896 | -697 | N/A |
| 3/31/2020 | 627 | -1,063 | -980 | -680 | N/A |
| 12/31/2019 | 476 | -861 | -1,194 | -784 | N/A |
| 9/30/2019 | 395 | -681 | -1,454 | -652 | N/A |
| 6/30/2019 | 365 | -475 | -1,477 | -546 | N/A |
| 3/31/2019 | 288 | -414 | -1,641 | -605 | N/A |
| 12/31/2018 | 282 | -368 | -1,451 | -466 | N/A |
| 9/30/2018 | 295 | -304 | -1,109 | -391 | N/A |
| 6/30/2018 | 330 | -251 | -884 | -313 | N/A |
| 3/31/2018 | 315 | -229 | -629 | -230 | N/A |
| 12/31/2017 | 298 | -175 | -549 | -190 | N/A |
| 9/30/2017 | 281 | -172 | N/A | -196 | N/A |
| 6/30/2017 | 258 | -167 | N/A | -183 | N/A |
| 3/31/2017 | 256 | -140 | N/A | -119 | N/A |
| 12/31/2016 | 253 | -112 | N/A | -54 | N/A |
| 9/30/2016 | 215 | -110 | N/A | -74 | N/A |
| 6/30/2016 | 176 | -107 | N/A | -93 | N/A |
| 3/31/2016 | 140 | -121 | N/A | -119 | N/A |
| 12/31/2015 | 103 | -135 | N/A | -146 | N/A |
| 12/31/2014 | 54 | -133 | N/A | -115 | N/A |
| 12/31/2013 | 9 | -105 | N/A | -86 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 6589 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).
Earnings vs Market: 6589 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 6589 is expected to become profitable in the next 3 years.
Revenue vs Market: 6589's revenue (42.3% per year) is forecast to grow faster than the TW market (10.5% per year).
High Growth Revenue: 6589's revenue (42.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 6589's Return on Equity is forecast to be low in 3 years time (3.9%).